Mr. Paul Levesque reports

THERATECHNOLOGIES TO ANNOUNCE THIRD QUARTER 2023 FINANCIAL RESULTS AND PROVIDE BUSINESS UPDATE

Theratechnologies Inc. will release financial results and provide a business update for its third quarter ended Aug. 31, 2023, on Tuesday, Sept. 26, at 8:30 a.m. EDT.

The call will be hosted by Paul Levesque, president and chief executive officer. Mr. Levesque will be joined by other members of the management team, including senior vice-president and chief financial officer, Philippe Dubuc, senior vice-president and chief medical officer, Dr. Christian Marsolais, and global commercial officer, John Leasure, who will be available to answer questions from participants following prepared remarks.

Participants are encouraged to join the call at least 10 minutes in advance to secure access.

Conference call dial-in and replay information is below.

Conference call information

Conference call date:  Sept. 26, 2023

Conference call time:  8:30 a.m. EDT

A webcast will be available.

Dial-in:  1-888-317-6003 (toll-free) or 1-412-317-6061 (international)

Access code:  9250897

An archived webcast will also be available on the company's investor relations website under past events.

About Theratechnologies Inc.

Theratechnologies (Toronto Stock Exchange: TH) (Nasdaq: THTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs.